Shingo Nagai

Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab

Koji Iinuma, Torai Enomoto, Kei Kawada et al. · Journal of Clinical Medicine · 2021 · 37 citations · Full text

Medicine, Immunology, Oncology +17

Response to nivolumab in metastatic collecting duct carcinoma expressing PD‑L1: A case report

Kosuke Mizutani, Kengo Horie, Shingo Nagai et al. · Molecular and Clinical Oncology · 2017 · 32 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study

Koji Iinuma, Koji Kameyama, Kei Kawada et al. · Current Oncology · 2021 · 18 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Real-World Cohort Study

Koji Iinuma, Toyohiro Yamada, Koji Kameyama et al. · Cancers · 2023 · 18 citations · Full text

Medicine, Oncology, Pharmacotherapy +17